ImmuCell Welcomes New CFO to Drive Strategic Growth
Timothy Fiori Named CFO of ImmuCell Corporation

.webp&w=1920&q=75&dpl=dpl_DvHKTkTrxtw9jHK6MpkEndZCmmr3)
ImmuCell Corporation, a Maine-based leader in animal health solutions for dairy and beef cattle, has announced the appointment of Timothy C. Fiori as its new Chief Financial Officer. Fiori joins the team with over two decades of experience at IDEXX Laboratories, bringing with him a strong background in finance and commercial operations. A University of Maine graduate and Maine native, he’s now taking on a key leadership role at a time when ImmuCell is focused on scaling up its proven portfolio of cattle health products.
“I’m thrilled to be part of a company with such meaningful impact and exciting momentum,” said Fiori. “There’s so much potential to build on, and I’m ready to contribute right away.” President and CEO Michael F. Brigham echoed that enthusiasm, noting Fiori’s arrival as “a critical step” in optimizing operations, enhancing financial systems, and identifying new efficiencies. With Fiori’s hands-on leadership style and deep industry insight, ImmuCell is poised to strengthen its financial foundation and accelerate its growth journey.

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.
Más de Pharma News
Todos los artículos →
Medicus Pharma presenta al FDA el protocolo combinado de fase 2b/3 para Teverelix

Fresenius Kabi recibe una carta de advertencia de la FDA tras fallos en la investigación del procesamiento aséptico en la planta de Melrose Park

Discussion